Cytosorbents (CTSO) Enterprise Value (2010 - 2026)
Cytosorbents (CTSO) posted Enterprise Value of -$4.8 million for Q1 2026, up 23.19% on a QoQ basis from -$6.2 million in Q4 2025, and up 63.39% year-over-year from -$2.9 million in Q1 2025.
Cytosorbents (CTSO) Enterprise Value (2010 - 2026) Analysis & Trends
Cytosorbents' Enterprise Value history runs 17 years deep, the most recent figure standing at -$4.8 million for Q1 2026.
- Quarterly Enterprise Value rose 63.39% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (up 63.39% YoY) and the FY2025 annual result came in at -$6.2 million, up 57.67% from the prior year.
- Enterprise Value was -$4.8 million for Q1 2026 at Cytosorbents, up from -$6.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.8 million in Q1 2026 and bottomed at -$43.0 million in Q1 2022.
- A 5-year average of -$14.9 million and a median of -$13.1 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value tumbled 52.29% — and 2026, when it soared 63.39%.
- Cytosorbents' Enterprise Value stood at -$22.1 million in 2022, then soared by 36.19% to -$14.1 million in 2023, then decreased by 4.48% to -$14.8 million in 2024, then jumped by 57.67% to -$6.2 million in 2025, then rose by 23.19% to -$4.8 million in 2026.
- Business Quant data shows CTSO's Enterprise Value at -$4.8 million in Q1 2026, -$6.2 million in Q4 2025, and -$7.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -4.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.80 Mn |
| Dec 31, 2025 | -6.25 Mn |
| Sep 30, 2025 | -7.54 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Dec 31, 2024 | -14.76 Mn |
| Sep 30, 2024 | -6.50 Mn |
| Jun 30, 2024 | -8.46 Mn |
| Mar 31, 2024 | -8.61 Mn |
| Dec 31, 2023 | -14.13 Mn |
| Sep 30, 2023 | -8.36 Mn |
| Jun 30, 2023 | -13.15 Mn |
| Mar 31, 2023 | -19.05 Mn |
| Dec 31, 2022 | -22.14 Mn |
| Sep 30, 2022 | -22.55 Mn |
| Jun 30, 2022 | -30.16 Mn |
| Mar 31, 2022 | -43.02 Mn |
| Dec 31, 2021 | -52.14 Mn |
| Sep 30, 2021 | -61.04 Mn |
| Jun 30, 2021 | -65.61 Mn |